# OnCo record paper-schroder-erspc-screening-mortality-nejm-2009 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-schroder-erspc-screening-mortality-nejm-2009/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-schroder-erspc-screening-mortality-nejm-2009" ;
  schema:name "ERSPC: screening and prostate cancer mortality in a randomised European study"@en ;
  schema:alternateName "ERSPC"@en, "European Randomized Study of Screening for Prostate Cancer"@en, "Schroder 2009"@en ;
  schema:description "The trial that showed PSA screening does save lives, and showed what it costs. Screening cut the death rate from prostate cancer by a fifth, but 1,410 men had to be screened and 48 extra cancers treated to prevent one death."@en ;
  schema:url <https://onco.cc/key-papers/paper-schroder-erspc-screening-mortality-nejm-2009/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa0810084>, <https://pubmed.ncbi.nlm.nih.gov/19297566/>, <https://www.isrctn.com/ISRCTN49127736> ;
  onco:tag "prostate-evidence" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa0810084> ;
  schema:datePublished "2009"^^xsd:gYear ;
  schema:author "Schröder FH, Hugosson J, Roobol MJ, et al." ;
  onco:related <https://onco.cc/key-papers/paper-andriole-plco-prostate-screening-nejm-2009/>, <https://onco.cc/key-papers/paper-hugosson-eur-urol/>, <https://onco.cc/key-papers/paper-draisma-lead-time-overdiagnosis-psa-jnci-2009/>, <https://onco.cc/key-papers/paper-goteborg-2-n-engl-j-med-2022/>, <https://onco.cc/roadmaps/early-detection-roadmap/>, <https://onco.cc/roadmaps/prostate-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate-intermediate-risk/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:sections <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/prostate-screening-psa-mri/> ;
  onco:terms <https://onco.cc/terms/psa/>, <https://onco.cc/terms/screening/>, <https://onco.cc/terms/overdiagnosis/>, <https://onco.cc/terms/number-needed-to-screen/>, <https://onco.cc/terms/lead-time-bias/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-overdiagnosis/>, <https://onco.cc/bottlenecks/b-prevention-adoption/> ;
  onco:journals <https://onco.cc/journals/nejm/> .
